Alpha 2.0
Login Register
» Articles » PMID: 39532066

Long-term Breast Cancer Response to CDK4/6 Inhibition Defined by TP53-mediated Geroconversion

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2024 Nov 12
PMID 39532066
Authors
Rei Kudo
Anton Safonov
Catherine Jones
Enrico Moiso
Jonathan R Dry
Hong Shao
Sharanya Nag
Edaise M da Silva
Selma Yeni Yildirim
Qing Li
Elizabeth OConnell
Payal Patel
Marie Will
Atsushi Fushimi
Marimar Benitez
Martina Bradic
Li Fan
Harikrishna Nakshatri
Dhivya R Sudhan
Christopher R Denz
Jorge S Reis-Filho
Shom Goel
Andrew Koff
Britta Weigelt
Qamar J Khan
Pedram Razavi
Sarat Chandarlapaty
Affiliations
Soon will be listed here.
Citing Articles

Emerging Role of the DREAM Complex in Cancer and Therapeutic Opportunities.

Hwang Y, Kim M Int J Mol Sci. 2025; 26(1.

PMID: 39796178 PMC: 11719884. DOI: 10.3390/ijms26010322.

Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer.

Armand J, Kim S, Kim K, Son E, Kim M, Yang H bioRxiv. 2024; .

PMID: 39605351 PMC: 11601343. DOI: 10.1101/2024.11.11.623139.